Berger Financial Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.63M | Buy |
14,187
+53
| +0.4% | +$9.84K | 0.17% | 112 |
|
|
2025
Q1 | $2.96M | Sell |
14,134
-780
| -5% | -$163K | 0.21% | 105 |
|
|
2024
Q4 | $2.65M | Buy |
14,914
+885
| +6% | +$157K | 0.18% | 112 |
|
|
2024
Q3 | $2.77M | Buy |
14,029
+8,089
| +136% | +$1.6M | 0.2% | 101 |
|
|
2024
Q2 | $1.02M | Buy |
5,940
+336
| +6% | +$57.6K | 0.08% | 152 |
|
|
2024
Q1 | $1.02M | Buy |
5,604
+234
| +4% | +$42.6K | 0.08% | 148 |
|
|
2023
Q4 | $832K | Sell |
5,370
-101
| -2% | -$15.7K | 0.09% | 130 |
|
|
2023
Q3 | $816K | Sell |
5,471
-282
| -5% | -$42K | 0.09% | 127 |
|
|
2023
Q2 | $775K | Buy |
5,753
+14
| +0.2% | +$1.89K | 0.09% | 127 |
|
|
2023
Q1 | $915K | Buy |
5,739
+449
| +8% | +$71.6K | 0.11% | 113 |
|
|
2022
Q4 | $855K | Buy |
5,290
+863
| +19% | +$139K | 0.11% | 113 |
|
|
2022
Q3 | $594K | Buy |
4,427
+299
| +7% | +$40.1K | 0.09% | 129 |
|
|
2022
Q2 | $632K | Buy |
4,128
+99
| +2% | +$15.2K | 0.09% | 117 |
|
|
2022
Q1 | $653K | Buy |
4,029
+48
| +1% | +$7.78K | 0.08% | 128 |
|
|
2021
Q4 | $539K | Buy |
3,981
+842
| +27% | +$114K | 0.07% | 143 |
|
|
2021
Q3 | $339K | Buy |
3,139
+1
| +0% | +$108 | 0.06% | 148 |
|
|
2021
Q2 | $354K | Sell |
3,138
-189
| -6% | -$21.3K | 0.06% | 143 |
|
|
2021
Q1 | $360K | Sell |
3,327
-150
| -4% | -$16.2K | 0.08% | 136 |
|
|
2020
Q4 | $373K | Buy |
+3,477
| New | +$373K | 0.07% | 145 |
|